Decisive Diagnostics

Decisive Diagnostics is a medical diagnostics company developing a point-of-care platform for rapid antimicrobial susceptibility testing (AST). Spun out of Cornell University, the company addresses the critical need for faster diagnosis in sepsis and bloodstream infections, where every hour of delay in correct antibiotic administration increases mortality. Their technology utilizes microfluidic systems to provide phenotypic susceptibility results directly from blood samples in under four hours. This approach bypasses the lengthy incubation periods required by conventional methods, facilitating precision medicine in infectious disease management. By providing clinicians with actionable data faster, the company seeks to improve patient outcomes and promote antibiotic stewardship.